Skip to main content
Clinical Trials/NCT03437681
NCT03437681
Active, not recruiting
Not Applicable

Tissue-specific Effects of Insufficient Sleep

University of Colorado, Denver1 site in 1 country18 target enrollmentFebruary 12, 2018
ConditionsHealthy

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Healthy
Sponsor
University of Colorado, Denver
Enrollment
18
Locations
1
Primary Endpoint
Change in insulin sensitivity
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

This study plans to learn more about how sleep loss impacts the way the body responds to sugar. This work will have important implications for development of treatments and countermeasures for people who are not able to get enough sleep for various reasons.

Detailed Description

Participants will stay in the hospital for 6 days and will not be able to leave. Sleep habits will be measured for 7 days before the study. A research diet that is designed to maintain weight will be provided for 3 days before the study and during the study. Multiple tests will be performed, including metabolic testing and muscle and fat biopsies, both when participants first arrive and have had normal sleep and again after 4 nights of only 5 hours time in bed. The visit takes place at the Clinical Translational Research Center (CTRC) at the University of Colorado Denver, Anschutz Medical campus. It will take approximately 2 weeks to complete this study.

Registry
clinicaltrials.gov
Start Date
February 12, 2018
End Date
December 30, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Current or history of any clinically significant medical, psychiatric, or sleep disorder.
  • Use or history of any drugs, medications, supplements, caffeine, and alcohol.
  • Current or history of shiftwork in six months prior to laboratory study.
  • Travel more than one time zone in three weeks prior to laboratory study.
  • Blood donation in the 30 days prior to inpatient study.

Outcomes

Primary Outcomes

Change in insulin sensitivity

Time Frame: One week

Insulin sensitivity measured by hyperinsulinemic euglycemic clamp.

Secondary Outcomes

  • Changes in microvascular function(One week)
  • Changes in cognitive abilities(One week)
  • Changes in metabolic tissue function(One week)
  • Changes in macrovascular function(One week)
  • Changes in circadian rhythms(One week)

Study Sites (1)

Loading locations...

Similar Trials